ECSP088947A - Profarmacos de penem - Google Patents

Profarmacos de penem

Info

Publication number
ECSP088947A
ECSP088947A EC2008008947A ECSP088947A ECSP088947A EC SP088947 A ECSP088947 A EC SP088947A EC 2008008947 A EC2008008947 A EC 2008008947A EC SP088947 A ECSP088947 A EC SP088947A EC SP088947 A ECSP088947 A EC SP088947A
Authority
EC
Ecuador
Prior art keywords
profarms
penem
sulopenem
prodrugs
solvates
Prior art date
Application number
EC2008008947A
Other languages
English (en)
Inventor
Anthony Marfat
Dale Gordon Mcleod
Katherine E Brighty
Donnell John Paul O
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ECSP088947A publication Critical patent/ECSP088947A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/887—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Profármacos de sulopenem con biodisponibilidad por vía oral, por ejemplo (consta gráfico) y sus solvatos e hidratos, su preparación, su formulación y su uso para tratar y prevenir la infección en mamíferos tales como seres humanos. Este resumen no limita la invención.
EC2008008947A 2006-06-28 2008-12-08 Profarmacos de penem ECSP088947A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80600006P 2006-06-28 2006-06-28
US91158707P 2007-04-13 2007-04-13

Publications (1)

Publication Number Publication Date
ECSP088947A true ECSP088947A (es) 2009-01-30

Family

ID=38463109

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008947A ECSP088947A (es) 2006-06-28 2008-12-08 Profarmacos de penem

Country Status (28)

Country Link
US (2) US7795243B2 (es)
EP (1) EP2044085B1 (es)
JP (2) JP4397435B2 (es)
KR (1) KR101060448B1 (es)
AP (1) AP2008004705A0 (es)
AR (1) AR061646A1 (es)
AT (1) ATE493419T1 (es)
AU (1) AU2007263519B2 (es)
BR (1) BRPI0712740A2 (es)
CA (1) CA2655485C (es)
CL (1) CL2007001910A1 (es)
CR (1) CR10467A (es)
DE (1) DE602007011622D1 (es)
DK (1) DK2044085T3 (es)
EA (1) EA200870584A1 (es)
EC (1) ECSP088947A (es)
GT (1) GT200700050A (es)
IL (1) IL195383A0 (es)
MA (1) MA30568B1 (es)
MX (1) MX2009000116A (es)
NL (1) NL2000715C2 (es)
NO (1) NO20090392L (es)
PE (1) PE20080940A1 (es)
SV (1) SV2008003139A (es)
TN (1) TNSN08537A1 (es)
TW (1) TW200816999A (es)
UY (1) UY30439A1 (es)
WO (1) WO2008001212A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20080940A1 (es) * 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
US20080125408A1 (en) * 2006-11-14 2008-05-29 Pfizer Inc Penem prodrug
WO2009108704A1 (en) * 2008-02-25 2009-09-03 Semafore Pharmaceuticals, Inc. O-alkylated pi-3 kinase inhibitor prodrug combination
KR100916052B1 (ko) 2009-02-24 2009-09-08 코오롱건설주식회사 진공이송 쓰레기 수거시스템의 쓰레기 배출밸브
BR112012002780A2 (pt) * 2009-08-10 2017-02-21 Bellus Health Inc métodos, compostos, e composições para a aplicação de ácido 1,3-propanodisulfônico
US11554112B2 (en) * 2018-06-07 2023-01-17 Herum Therapeutics International Limited Combinations of β-lactam compounds and probenecid and uses thereof
TWI908716B (zh) * 2019-02-13 2025-12-21 愛爾蘭商伊泰倫醫療國際有限公司 β-內醯胺化合物及丙磺舒之組合及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619924A (en) 1984-05-18 1986-10-28 Pfizer Inc. 2-alkylthiopenem derivatives
US4870170A (en) * 1985-10-17 1989-09-26 Pfizer Inc. Process for 2-(1-oxo-3-thiolanyl)-2-penem antibiotics
US5013729A (en) * 1987-05-11 1991-05-07 Pfizer Inc. Diastereomeric 5R,6S-6-(1R-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids
GB8713515D0 (en) 1987-06-10 1987-07-15 Erba Farmitalia Methoxymethyl compounds
US4874877A (en) * 1988-04-19 1989-10-17 Pfizer Inc. Process for optically active 3-(methane-sulfonyloxy)thiolane and analogs
EP0544905B1 (en) 1990-08-20 1998-10-14 Suntory Limited Antibacterial penem compounds
JP3148236B2 (ja) 1990-08-20 2001-03-19 サントリー株式会社 ペネム化合物
WO2004067532A1 (ja) 2003-01-31 2004-08-12 Meiji Seika Kaisha, Ltd. 新規カルバペネム誘導体
PE20080940A1 (es) * 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
EP2043728A2 (en) * 2006-07-11 2009-04-08 Microchips, Inc. Multi-reservoir pump device for dialysis, biosensing, or delivery of substances
US20080125408A1 (en) * 2006-11-14 2008-05-29 Pfizer Inc Penem prodrug

Also Published As

Publication number Publication date
AU2007263519A1 (en) 2008-01-03
JP4397435B2 (ja) 2010-01-13
MA30568B1 (fr) 2009-07-01
US20090042853A1 (en) 2009-02-12
KR101060448B1 (ko) 2011-08-29
EP2044085A2 (en) 2009-04-08
TW200816999A (en) 2008-04-16
JP2009542616A (ja) 2009-12-03
WO2008001212A3 (en) 2008-03-20
AP2008004705A0 (en) 2008-12-31
GT200700050A (es) 2008-02-01
WO2008001212A2 (en) 2008-01-03
CA2655485A1 (en) 2008-01-03
NO20090392L (no) 2009-01-27
DK2044085T3 (da) 2011-03-07
KR20090015147A (ko) 2009-02-11
CL2007001910A1 (es) 2008-01-11
US20080009474A1 (en) 2008-01-10
HK1134928A1 (en) 2010-05-20
SV2008003139A (es) 2010-01-12
CA2655485C (en) 2011-08-02
NL2000715A1 (nl) 2008-01-02
MX2009000116A (es) 2009-01-23
IL195383A0 (en) 2009-08-03
JP2010013468A (ja) 2010-01-21
NL2000715C2 (nl) 2008-03-11
AR061646A1 (es) 2008-09-10
JP5152527B2 (ja) 2013-02-27
BRPI0712740A2 (pt) 2012-06-05
EP2044085B1 (en) 2010-12-29
AU2007263519B2 (en) 2011-05-19
EA200870584A1 (ru) 2009-06-30
PE20080940A1 (es) 2008-07-09
ATE493419T1 (de) 2011-01-15
US7795243B2 (en) 2010-09-14
US7795244B2 (en) 2010-09-14
CR10467A (es) 2009-01-19
DE602007011622D1 (en) 2011-02-10
TNSN08537A1 (fr) 2010-04-14
UY30439A1 (es) 2008-01-31

Similar Documents

Publication Publication Date Title
PH12017501298A1 (en) Pesticidal compositions and processes related thereto
PH12017502300A1 (en) Pesticidal compositions and processes related thereto
ECSP088947A (es) Profarmacos de penem
UY32327A (es) Antagonistas de receptores de ácido lisofosfatídico
CR20120158A (es) Compuestos de diòxido de iminotiadiazina como inhibidores de bace, composiciones y su uso.
CY1118062T1 (el) Συνθεσεις για την αντιμετωπιση της ναυτιας και του εμετου κεντρικης προελευσης
PH12014502397B1 (en) Pesticidal compositions and processes related thereto
CL2011000527A1 (es) Compuestos derivados de benzofurano; composicion farmaceutica que los comprende;y su uso en el tratamiento de la hepatitis c.
PH12014500930A1 (en) Pesticidal compositions and processes related thereto
PH12014500910A1 (en) Pesticidal compositions and processes related thereto
MX2015008072A (es) Composiciones plaguicidas y los procedimientos relacionados con las mismas.
EA201170832A1 (ru) Пуриновые соединения
CL2011002942A1 (es) Compuestos derivados de 2,4-diamino-pirimidina, agonistas de receptor tipo toll-7 (tlr7); composicion farmaceutica; y su uso para el tratamiento del cancer.
MX388468B (es) Compuestos multicíclicos y métodos de uso de los mismos.
HN2008001464A (es) Formulaciones para administrcion parenteral de compuestos y sus usos
UY33616A (es) Compuestos con estructura de imidazotriazinona
MX2015008065A (es) Composiciones pesticidas y procesos relacionados con ellas.
CR20130306A (es) Compuestos y su uso
UY32029A (es) "derivados de pirazolo -[5.1-b] - oxazol, su prepraración, composiciones farmacéuticas que los contienen y aplicaciones"
MX2010008852A (es) Formulaciones de flibanserina.
CL2011000168A1 (es) Compuestos derivados de narciclasina y pancratistatina; procedimiento de preparación; composición farmacéutica; combinación farmacéutica; y su uso para el tratamiento del cáncer.
PA8797801A1 (es) Uso de n-fenilamidas de acido 2-sulfonilaminobenzoico sustituidas con sulfonilo en el tratamiento del dolor
CO7160067A2 (es) Formulaciones de agonistas del receptor de somatostatina
DOP2012000077A (es) Composiciones y metodos para tratar infecciones bacterianas utilizando ceftarolina
IT1395351B1 (it) Formulazioni orali ad elevata biodisponibilita' orale costituite da miscele di frazioni lipofile e idrofile ottenute a partire dalla propoli